British Patient Capital

British Patient Capital is a subsidiary of British Business Bank, the UK government-backed economic development bank, established in 2018 to address the chronic shortage of patient long-term capital for ambitious, growth-oriented technology companies in the United Kingdom. Unlike most venture capital funds, British Patient Capital does not invest directly in companies but operates as a fund-of-funds, committing capital to independent venture capital and growth equity managers who in turn invest in UK technology businesses. This structure allows British Patient Capital to allocate substantial capital across the UK venture ecosystem efficiently while leveraging the investment expertise and portfolio selection capabilities of experienced private sector fund managers. British Patient Capital manages more than £2.5 billion in commitments, making it one of the largest sources of institutional capital for UK venture funds, and has backed more than 70 venture and growth funds since its establishment. The mandate is deliberately patient in nature: British Patient Capital can make fund commitments with longer horizons than typical institutional LPs, enabling it to support funds investing in hardware, deep tech, life sciences, and other sectors where the time from investment to exit or liquidity is longer than software-focused venture. The original directory notes the portfolio as fund-of-funds indirect investments, which accurately reflects that British Patient Capital does not hold direct stakes in portfolio companies but rather participates in returns through its limited partner positions in the venture funds it backs. The managers backed by British Patient Capital include both established UK venture firms and emerging managers, with investments spanning seed through late growth stages.